Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,087 across all filing types
Latest filing 2023-05-12 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, Horizon Therapeutics PLC). This type of filing is a standard regulatory disclosure regarding major shareholding and dealing activity during an M&A event. Since it does not fit into the specific categories of 'Major Shareholding Notification' (which usually refers to threshold crossing announcements by the company or major holders) or 'M&A Activity' (which usually refers to the offeror/offeree's own announcements), it is best classified as a Regulatory Filing (RNS).
2023-05-12 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 96% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities by a person (Citadel Group) with interests representing 1% or more in an offeror/offeree (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement for M&A activity, but since it is a mandatory disclosure of shareholdings and dealings rather than a merger announcement itself, it falls under the category of Regulatory Filings (RNS) as it is distributed via the Regulatory News Service.
2023-05-11 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 96% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act for persons with interests in relevant securities representing 1% or more during a takeover offer. It details shareholdings, dealings, and derivative positions of Citadel Group in relation to Horizon Therapeutics PLC. This is a specific regulatory disclosure document rather than a general announcement or a report, and it fits the 'Major Shareholding Notification' category as it reports significant ownership and changes in position.
2023-05-10 English
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act. It details shareholdings, positions, and dealings in the securities of 'HORIZON THERAPEUTICS PLC' by 'Citadel Group'. This is a standard regulatory notification used to report significant shareholding changes and market activity during a takeover or merger process. It does not fit into the specific categories of 'Director's Dealing' (which is for company insiders) or 'Major Shareholding Notification' (which is for general threshold crossings), but rather falls under the broader regulatory disclosure requirements for takeover-related activities. Given the specific nature of the Irish Takeover Panel disclosure, it is classified as a Regulatory Filing.
2023-05-09 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in relation to an offeror or offeree during a takeover period. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports significant ownership levels and changes in holdings, which is the standard classification for Rule 8.3 disclosures in financial databases.
2023-05-09 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of regulatory disclosure regarding shareholdings and dealings during a takeover process is classified as a Major Shareholding Notification (MRQ) within the provided schema, as it details significant ownership and transaction activity.
2023-05-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.